Anumana

Anumana is an AI-driven health technology company that develops and commercializes AI software solutions to improve patient care throughout the cardiac care continuum. Focused on unlocking the language of the heart, Anumana uses cutting-edge AI algorithms to analyze electrocardiograms (ECGs) and other electrophysiological data, enabling earlier and more accurate diagnosis of cardiovascular diseases. Their solutions, developed in collaboration with Mayo Clinic and other leading institutions, aim to detect hidden conditions earlier, allowing for more timely interventions and better patient outcomes.

Anumana's primary focus is on ECG-AI, with a robust pipeline of algorithms in development. Their flagship product, ECG-AI LEF, is an FDA-cleared AI algorithm that detects low ejection fraction (LEF), a key indicator of heart failure, using standard 12-lead ECGs. Beyond LEF, Anumana has algorithms targeting other cardiovascular diseases, including pulmonary hypertension, cardiac amyloidosis, and hyperkalemia. The company also develops software solutions for seamless integration with existing clinical workflows, ensuring that its AI technology can be easily adopted by clinicians.

Anumana, an AI-driven health technology company, is on a mission to unlock the language of the heart by leveraging cutting-edge artificial intelligence to transform cardiac care. Their AI solutions, developed in collaboration with Mayo Clinic, aim to detect diseases earlier, improve treatment, and enhance interventional procedures through real-time AI insights. With a focus on precision medicine, Anumana is committed to improving patient care throughout the cardiac care continuum.

Anumana fosters a collaborative and innovative culture centered around leveraging cutting-edge AI to improve cardiac care. The company emphasizes a strong commitment to scientific rigor and working closely with leading clinical experts, as evidenced by their partnerships with Mayo Clinic and other academic medical centers. This focus on collaboration and scientific excellence is further demonstrated through their robust pipeline of FDA-ready ECG-AI algorithms, which are validated through extensive research and numerous peer-reviewed publications.